Loading...
XNYSGMED
Market cap11bUSD
Jan 10, Last price  
87.07USD
1D
0.60%
1Q
23.38%
Jan 2017
250.95%
IPO
544.96%
Name

Globus Medical Inc

Chart & Performance

D1W1MN
XNYS:GMED chart
P/E
96.49
P/S
7.56
EPS
0.90
Div Yield, %
0.00%
Shrs. gr., 5y
2.50%
Rev. gr., 5y
17.08%
Revenues
1.57b
+53.34%
254,344,000288,195,000331,478,000385,994,000434,459,000474,371,000544,753,000563,994,000635,977,000712,969,000785,368,000789,042,000958,102,0001,022,843,0001,568,476,000
Net income
123m
-35.39%
48,733,00054,458,00060,784,00073,831,00068,612,00092,485,000112,784,000104,341,000107,348,000156,474,000155,210,000102,285,000149,191,000190,169,000122,873,000
CFO
243m
+36.44%
32,079,00071,288,00076,410,00076,519,00093,471,00079,172,000121,957,000171,893,000159,535,000181,643,000171,975,000198,793,000276,274,000178,468,000243,499,000
Earnings
Feb 18, 2025

Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
IPO date
Mar 08, 2012
Employees
2,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,568,476
53.34%
1,022,843
6.76%
Cost of revenue
672,184
336,740
Unusual Expense (Income)
NOPBT
896,292
686,103
NOPBT Margin
57.14%
67.08%
Operating Taxes
42,520
52,850
Tax Rate
4.74%
7.70%
NOPAT
853,772
633,253
Net income
122,873
-35.39%
190,169
27.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
(225,562)
(102,777)
BB yield
3.69%
1.35%
Debt
Debt current
11,967
2,536
Long-term debt
611,441
9,486
Deferred revenue
1,779
Other long-term liabilities
102,919
63,516
Net debt
30,191
(929,888)
Cash flow
Cash from operating activities
243,499
178,468
CAPEX
(78,274)
(74,047)
Cash from investing activities
302,968
(110,362)
Cash from financing activities
(231,821)
(109,962)
FCF
(189,794)
605,301
Balance
Cash
517,789
446,058
Long term investments
75,428
495,852
Excess cash
514,793
890,768
Stockholders' equity
1,127,210
1,215,421
Invested Capital
4,106,489
1,025,921
ROIC
33.27%
64.16%
ROCE
19.05%
35.76%
EV
Common stock shares outstanding
114,630
102,643
Price
53.29
-28.25%
74.27
2.87%
Market cap
6,108,633
-19.87%
7,623,296
1.89%
EV
6,138,824
6,693,408
EBITDA
1,041,025
754,355
EV/EBITDA
5.90
8.87
Interest
14,233
Interest/NOPBT
2.07%